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Abstract Neurogenic bowel dysfunction occurs in a large
percentage of adult patients with spina bifida (SB) and spinal
cord injury (SCI), significantly affecting their quality of life.
Although bowel motility is autonomously regulated by the
enteric nervous system (ENS), disruption of the modulation
of the ENS by extrinsic innervation as present in many pa-
tients with SB and SCI might lead to motility disorders. In
order to gain insight in the pathophysiology, we studied his-
tological changes of the neuromuscular structures in the colon
of SB and SCI patients. Archival colon tissue blocks from SB
(n = 13) and SCI (n = 34) patients were collected nationwide
in The Netherlands and compared with control samples
(n = 16). Histological (semiquantitative) evaluation of the
ENS, the network of interstitial cells of Cajal (ICC), and the
muscularis propria was performed using hematoxylin and eo-
sin, periodic acid Schiff, and elastic von Gieson staining, and
immunohistochemistry with antibodies against HuC/D,
calretinin, S100, CD117, α-smooth muscle actin, and desmin.
Compared to controls, SB and SCI patients showed neuronal
loss and decreased nerve fiber density in the myenteric plexus.
Lower nerve fiber density was significantly more often found
in patients with severe bowel dysfunction. Other major find-
ings were loss of ICCs around the myenteric plexus and fibro-
sis in the longitudinal muscle layer. Altered histology of the
ENS may explain abnormal intestinal motility in SB and SCI
patients. Furthermore, loss of myenteric nerve fibers (includ-
ing enteric glial cells) may play a major role in the develop-
ment of severe motility complaints.
Keywords Colon . Immunohistochemistry . Intestinal
motility . Neuromuscular disease . Spina bifida . Spinal cord
injury
Abbreviations
CNS Central nervous system
ENS Enteric nervous system
EVG Elastic von Gieson
GINMD Gastrointestinal neuromuscular disease
H&E Hematoxylin and eosin
ICC Interstitial cell of Cajal
IPAN Intrinsic primary afferent neuron
PAS Periodic acid Schiff
SB Spina bifida
SCI Spinal cord injury
SMA Smooth muscle actin
Introduction
Spina bifida (SB) and spinal cord injury (SCI) are both disor-
ders of the central nervous system (CNS). Neurogenic bowel
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dysfunction is very common following SB and SCI, in ap-
proximately 40% and 42–81% of adult patients, respectively
[1–3]. In 39% of SCI patients, colorectal dysfunction has a
variable but sometimes significant impact on social activities
or quality of life [2, 4]. Main symptoms include loss of bowel
control (fecal incontinence), constipation, and lack of bowel
movements [1, 5–8]. The occurrence of these complications
depends at least partly on the type and the level of the lesion
and the time since the injury [3, 9].
Motility and secretion in the colon are controlled by both
intrinsic and extrinsic innervation. The intrinsic enteric ner-
vous system (ENS) has two major parts: the submucosal plex-
us and the myenteric plexus, which are located between the
circular and longitudinal layers of the muscularis propria. The
submucosal plexus mainly controls mucosal secretion and
blood flow, while the myenteric plexus is primarily involved
in coordination of motility patterns [10, 11]. One of the local
reflexes regulated by the ENS is the peristaltic reflex, which is
responsible for normal propulsion of bowel contents. Neurons
involved in this reflex include (sensory) intrinsic primary af-
ferent neurons (IPANs), interneurons and motor neurons.
Motor neurons give excitatory and inhibitory signals via the
interstitial cells of Cajal (ICCs) to smooth muscle cells [12].
Enteric ganglia contain both neurons and glial cells, which
play a supportive role to the neurons. Enteric glial cells are
increasingly recognized as important for regulatory functions
in the gut, such as the control of motility [13]. Although ICC
networks are found in different layers of the bowel wall, the
ICC network around the circumference of the myenteric plex-
us may play a major role in peristalsis [14–16].
The ENS functions largely independently of the CNS, al-
though extrinsic input from the sympathetic and parasympa-
thetic nerves modulates the activity of the ENS [17, 18].
Parasympathetic fibers facilitate contraction of the colon mus-
culature, and sympathetic fibers inhibit colon motility [19].
Hence, disruption of the extrinsic nerve fibers as in SB and
SCI has a major effect on ENS activity and results in abnormal
motor function [20]. The resulting intestinal dysfunction is
called neurogenic bowel [4]. This clinically well-known phe-
nomenon is rarely studied on morphological level [21].
Morphological analysis of motility disorders is difficult,
since a wide variety of morphological and functional alter-
ations of the ENS, ICCs, and smooth muscle tissue may result
in gastrointestinal neuromuscular diseases (GINMDs).
Despite the recent introduction of a classification of these
alterations by an International Working Group [22], the corre-
lation between clinical manifestations and morphological
findings remains challenging due to the lack of systematic
studies. Therefore, we performed this nationwide study to
evaluate the histopathology of the colon in SB and SCI. This
is the first systematic study investigating morphological alter-
ations in these patient groups, which might provide additional
insight into the underlying pathophysiology of bowel
dysfunction in SB and SCI. Since the etiology of SB and
SCI varies, different histological features might be expected
in both groups.
The aim of this study was to describe histological alter-
ations of the neuromuscular apparatus in the colon following
SB and SCI. Systematic (semiquantitative) assessment in-
volved themain relevant neuromuscular structures of the bow-
el (ENS, ICCs, smooth muscle). We applied the proposed
international guidelines on histological reporting for gastroin-
testinal neuromuscular pathologies [22, 23].
Methods
Subjects
Patients were selected using the nationwide network and reg-
istry of histopathology and cytopathology in The Netherlands
(PALGA database), which registers all pathology reports since
1991 [24]. Subsequently, archived formalin-fixed paraffin-
embedded tissue samples of colon segments were obtained
from patients with SB (n = 13) or SCI (n = 34) who underwent
surgical resection of part of the bowel. In seven patients, the
site of the removed segment was not indicated; in seven pa-
tients, this was the proximal bowel and in 33 patients the distal
bowel.
Control segments of the colon (n = 16) were obtained from
patients who underwent right-sided hemicolectomy for non-
obstructive colon carcinoma. Control patients showed no ev-
idence of gastrointestinal motility disorders. Tissue blocks
were obtained at a distance of ≥10 cm from the tumor, and
these were histologically confirmed as normal.
The study was approved by the local ethics committee (ref-
erence number 2014-1256). Samples were obtained in accor-
dance with the Code of Conduct of the Federation of Medical
Scientific Societies in the Netherlands [25].
Tissue preparation
Sections were cut from formalin-fixed paraffin-embedded
full-thickness tissue blocks for conventional histology or im-
munohistochemistry. In the patient groups, most sections were
transversal (SB n = 10; SCI n = 22), but some were longitu-
dinal (SB n = 1; SCI n = 5) or tangled (SB n = 3; SCI n = 8). In
the control group, only transversely oriented sections were
available.
Sections were deparaffinized by standard protocol in xy-
lene, rehydrated in an ethanol series, and rinsed in tap water.
Histological staining
Sections of 4 μmwere used for hematoxylin and eosin (H&E)
and periodic acid Schiff (PAS) staining. Elastic von Gieson
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(EVG) staining was performed on 6-μm sections. Tissues
were stained by standard protocols in a Medite TST 30 stainer
(Klinipath, Duiven, The Netherlands).
Immunohistochemistry
Immunohistochemical staining was performed on 4-μm sec-
tions. Antibodies, suppliers, and dilutions are listed in Table 1.
For HuC/D staining, antigen retrieval was performed in
sodium citrate (pH 6) at 100 °C for 30 min. Subsequently,
endogenous peroxidase was blocked with 3% hydrogen per-
oxide in PBS for 20 min. Sections were then rinsed in PBS
and incubated with primary antibody anti-HuC/D at 4 °C
overnight. After washing in PBS, sections were incubated
for 30 min with a secondary antibody (Powervision poly-
HRP anti Ms/Rb/Rt IgG, Immunologic , Duiven,
The Netherlands) at room temperature. Sections were finally
rinsed in PBS and immunoreactivity was developed with
PowerDAB (Immunologic) for 7 min at room temperature.
Subsequently, sections were rinsed in tap water, counter-
stained with hematoxylin, rinsed in tap water, dehydrated in
100% ethanol and xylene, and mounted with Permount.
The other immunohistochemical staining reactions were
performed in an automated LabVision Autostainer 480
(Klinipath, Duiven, The Netherlands). First, the method used
for antigen retrieval depended on the antibody (Table 1).
Subsequently, endogenous peroxidase was blocked with 3%
hydrogen peroxide in methanol for 10 min. Sections were
incubated with primary antibody for 60 min. Subsequently,
the sections were incubated with Powervision poly-HRP anti
Ms/Rb/Rt for 30 min, followed by staining with PowerDAB
for 7 min and counterstaining with hematoxylin for 1 min. All
incubations were performed at room temperature.
Tissue blocks containing different tissue types were used as
controls, with known staining patterns for both positive and
negative stained tissues.
Microscopic analysis
Sections were evaluated blind to diagnosis and were then
compared with those of the controls. The histology of the
bowel wall was examined by H&E. PAS was used to verify
the presence or absence of polyglucosan inclusion bodies in
the muscularis propria. The presence or absence of fibrosis
was assessed in the submucosa, muscularis propria, and
myenteric plexus on EVG-stained sections (Fig. 3c).
Immunohistochemically stained sections were assessed by
semiquantitative scoring using visual analysis to evaluate sys-
tematically the neuronal structures and smooth muscle layers.
The presence of neurons in ganglia was analyzed on HuC/
D- and calretinin-stained sections. The number of neurons in
relation to the present plexus was estimated in HuC/D sections
as follows: Firstly, the distribution of the neuronal network
was evaluated on S100-stained sections. Subsequently, the
number of neurons per ganglion was estimated in the HuC/
D staining in relation to this neuronal network and scored as 0,
no neurons; 1, low neuronal density; and 2, high neuronal
density (Suppl. Fig. 1). The calretinin-stained sections were
comparably rated: 0, no neurons; 1, on average less than one
neuron per neuronal structure; and 2, minimal one neuron per
neuronal structure (Suppl. Fig. 2).
S100 was used to assess the distribution of nerve fibers
(including nuclei of glial cells) in the submucosa, the
myenteric plexus, and both muscle layers of the muscularis
propria. The degree of distribution was scored as follows: 0
(no/low density) and 1 (high density of positive fibers) (Suppl.
Fig. 3).
The network of ICCs surrounding the myenteric plexus
was estimated on CD117-stained sections as described earlier
[26]. The percentage of the circumference which is covered by
CD117-positive cells was rated from 0 to 100% in 10% incre-
ments. Thus, a percentage of 0% represented no positive cells
around the ganglia and in sections estimated as 100% the
ganglia were completely surrounded by CD117-positive cells.
Staining of mast cells was used as internal positive control.
α-Smooth muscle actin (α-SMA) and desmin staining
were used to assess the muscularis layers. Staining intensities
of circular and longitudinal muscle layers were classified in
two grades: 0 (no/weak) and 1 (strong staining intensity)
(Suppl. Fig. 4). Immunoreactivity within blood vessel walls
and muscularis mucosae acted as internal reference for α-
SMA and desmin, respectively (grade 1).
Table 1 Primary antibodies used
for immunohistochemistry Antibody Clone Manufacturer Dilution Antigen retrieval
Calretinin 5A5 Novocastra 1:25 EDTA pH 9, 10 min at 96 °C
HuC/D 16A11 Molecular Probes 1:600 Sodium citrate 10 mM (pH 6.0),
30 min at 100 °C
S100 Polyclonal DAKO 1:10,000 EDTA pH 9, 10 min at 96 °C
CD117 YR145 Immunologic 1:200 None
α-Smooth muscle
actin (α-SMA)
1A4 Sigma 1:7500 None
Desmin 33 Biogenex 1:100 Citrate pH 6.7, 30 min at 100 °C
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Estimation of interobserver variation for the evaluation of
staining resulted in interobserver agreement of α-SMA
Balmost perfect^ (n = 17), HuC/D submucosal plexus Bfair^
(0.444), and myenteric plexus Bsubstantial^ (0.609) (n = 15).
Of cases with multiple slides, the slide with the lowest overall
scoring results was used for analysis.
Statistical analysis
Categorical variables were described by percentages.
Differences between categorical variables were assessed by
the chi-square test (likelihood ratio, exact p values compared
with the control group). Continuous variables were presented
as means ± standard deviation (SD). The Kruskal-Wallis test
with post hoc pairwise comparisons using the Dunn-
Bonferroni approach (SPSS procedure) was performed to
compare the CD117 scores between groups, computing ad-
justed p values corrected for multiple testing. A p value of
0.05 was considered significant. Data were analyzed by the
IBM SPSS Statistics 20 Software (SPSS Inc., Chicago, IL,
USA) and GraphPad Prism version 5.00 for Windows
(GraphPad Software, San Diego, CA, USA).
Results
SB and SCI patients underwent surgery for several reasons,
not limited to complaints that might be related to motility
disorders. Therefore, the SB and SCI groups were each divid-
ed into two subgroups: first, a subgroup with known (severe)
motility disorders which constituted the indication for bowel
resection (from here referred to as Bsymptomatic patients^;
SB: n = 7, SCI: n = 21) and, second, a subgroup in which
motility disorders were not listed in the anonymized patholo-
gy reports, although possibly present in less severe form (from
here referred to as Basymptomatic patients^; SB: n = 6, SCI:
n = 13). The latter subgroup included various indications for
resection: carcinoma, diverticulitis, and inflammatory bowel
disease (Crohn’s disease, ulcerative colitis). Table 2 shows
patient characteristics. An overview of the major results is
given in Suppl. Table 1.
H&E staining confirmed the normal histomorphology of
control specimens.
Neuronal changes
Submucosal plexus
The presence of neurons relative to nerve fibers in the submuco-
sal plexus was evaluated by HuC/D (all neurons) and calretinin
staining (part of intrinsic primary afferent neurons, IPANs).
On HuC/D staining (Fig. 1a–c), 31% of cases in the control
group were scored as high neuronal density. The symptomatic
and asymptomatic SB groups showed high neuronal density
in 29% (p = 1.000) and 17% (p = 0.130) of patients, respec-
tively. The symptomatic and asymptomatic SCI groups
showed high neuronal density in, respectively, 29%
(p = 1.000) and 9% (p = 0.350) of cases (Fig. 1a).
In the control group, at least one calretinin-positive neuron
per neuronal structure was present in 100% of cases. This was
significantly lower in both the symptomatic and the asymp-
tomatic SB group (43% (p = 0.004) and 33% (p = 0.002),
respectively). In SCI, only in the symptomatic subgroup was
neuronal density decreased (38%, p < 0.001), while in the
asymptomatic group, 77% of cases showed at least one neuron
per neuronal structure (p = 0.078) (Fig. 1d–f).
The density of nerve fibers was assessed by S100 staining
(Fig. 1g–i). Figure 1g demonstrates that in the control group,
94% of cases showed a high nerve fiber density. A high den-
sity was found in 86% of symptomatic SB cases (p = 1.000),
in 50% of asymptomatic SB patients (p = 0.046), in 62% of
symptomatic SCI cases (p = 0.050), and in 85% of asymptom-
atic SCI cases (p = 0.573).
Myenteric plexus
In the myenteric plexus, fewer neurons were observed in all
SB and SCI groups (Fig. 2a, d).
Table 2 Patient characteristics
Control (n = 16) SB SCI
Symptomatic (n = 7) Asymptomatic (n = 6) Symptomatic (n = 21) Asymptomatic
(n = 13)
Gender, n (%) Male 6 (37.5%) 6 (85.7%) 0 (0%) 10 (47.6%) 7 (35.8%)
Age, years (mean ± SD) 62.1 ± 12.9 15.1 ± 14.1 31.0 ± 9.8 55.4 ± 13.6 58.5 ± 14.8
Orientation cross
section, n (%)
Transversal 16 (100%) 4 (57.1%) 5 (83.3%) 14 (66.7%) 7 (53.8%)
Longitudinal 0 (0%) 1 (14.3%) 0 (0%) 4 (19.0%) 1 (7.7%)
Oblique 0 (0%) 2 (28.6%) 1 (16.7%) 3 (14.3%) 5 (38.5%)
SB spina bifida, SCI spinal cord injury, SD standard deviation
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On the HuC/D-stained sections (all neurons) (Fig. 2a–
c), 88% of cases in the control group were scored as high
neuronal density. In the symptomatic and asymptomatic
SB groups, 43% (p = 0.124) and 33% (p = 0.025) of
cases, respectively, showed a high neuronal density. The
symptomatic SCI group showed only in 33% of cases a
high density (p = 0.002), while 18% (p = 0.001) of the
asymptomatic SCI patients showed a high neuronal den-
sity (Fig. 2a).
On calretinin staining (part of IPANs) (Fig. 2d–f), neurons
were present, but less than one neuron per neuronal structure
in all control cases. The symptomatic SB group showed 86%
(p = 0.304) and the asymptomatic SB group 67% (p = 0.065)
of cases with on average less than one neuron per neuronal
structure. In the symptomatic and asymptomatic SCI groups,
86% (p = 0.495) and 85% (p = 0.192) of cases, respectively,
showed presence of neurons, although less than one neuron
per neuronal structure (Fig. 2d).
The S100 stain showed a lower density of nerve fi-
bers in SB and SCI compared with the control group
(Fig. 2g–i). All control cases showed a high nerve fiber
density. High densities were significantly less found in
the symptomatic SB group (42.9%, p = 0.004), while
66.7% of asymptomatic SB cases showed high densities
(p = 0.065). In SCI, high density was significantly less
often found in the symptomatic group (67%, p = 0.012),
and 77% of asymptomatic patients showed a high density
(p = 0.078).
The presence of fibrosis in the myenteric plexus was
assessed by EVG staining. As shown in Fig. 3a, no significant
differences between the control, SB, and SCI groups were
found.
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Fig. 1 Histological findings in the submucosal plexus of colon. a No
significant differences were found between the HuC/D-stained sections.
Most tissues showed low neuronal densities (grade 1) (b), while in some
sections, high neuronal densities (grade 2) were found (c). d Significantly
less calretinin-positive neurons were found in both SB groups and the
symptomatic SCI group compared with the control group. e Section with
neurons present, but less than one neuron per neuronal structure (grade 1).
fMinimal one neuron per neuronal structure is shown in this tissue (grade
2). g Low nerve fiber densities (grade 0) were most often observed in the
asymptomatic SB group. h, i Illustration of low (grade 0) (h) and high
(grade 1) (i) nerve fiber density. Numbers on the x-axis represent the
semiquantitative scores. C control, SB spina bifida, SCI spinal cord
injury. *p < 0.05 vs control. Scale bars 50 μm (b, c, e, f) and 200 μm
(h, i)
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Fig. 2 Histological findings in the myenteric plexus of colon. a
HuC/D-positive neurons were significantly less often found in the
asymptomatic SB group and both SCI groups compared with the
control group. b, c Examples of low (grade 1) (b) and high
neuronal density (grade 2) (c). d No differences in calretinin-
positive neurons were found between groups. e Tissue with no
neurons per neuronal structure (grade 0). f Example of tissue
with neurons present, but less than one neuron per neuronal
structure (grade 1). g Lower nerve fiber densities were
significantly more often found in the symptomatic SB and SCI
groups compared with the control group. h, i Representation of
low (grade 0) (h) and high (grade 1) (i) nerve fiber densities.
Numbers on the x-axis represent the semiquantitative scores. C
control, SB spina bifida, SCI spinal cord injury. *p < 0.05 vs
control. Scale bars 50 μm (b, c, e, f) and 200 μm (h, i)
a b c
Fig. 3 Presence of fibrosis in several layers of the bowel wall. a
Fibrosis was significantly more often found in the longitudinal
muscle layer of the SB and SCI groups. b Normal EVG
staining pattern in the longitudinal layer of the muscularis
propria (control). c Fibrosis in the longitudinal muscle layer,
showing excessive collagen accumulation. SB spina bifida, SCI
spinal cord injury, SM submucosa, CL circular layer, MP
myenteric plexus, LL longitudinal layer, EVG elastic von
Gieson. *p < 0.05 vs control, #p < 0.001 vs control. Scale bars
200 μm
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Nerve fibers within muscularis propria
In the circular muscle layer of the muscularis propria, a high
nerve fiber density (S100 staining) was found in 100% of
control cases. A significant decrease was seen in the symp-
tomatic SB group (57%, p = 0.020), but not in the asymptom-
atic SB group nor in the SCI group. In the longitudinal muscle
layer, no differences were observed (Suppl. Table 2).
ICC changes
Figure 4 shows the results of the estimation of the CD117-
positive ICC network around the circumference of themyenteric
plexus. Compared to the control group (mean 19.4 ± 18.1%),
fewer CD117-positive cells were observed in the SB groups
(symptomatic 5.7 ± 5.3%, p = 0.510 (p = 0.051 without correc-
tion for multiple testing) and asymptomatic 5.0 ± 5.5%,
p = 0.374 (p = 0.037 without correction)) and SCI groups
(symptomatic 5.2 ± 6.0%, p = 0.029 (p = 0.003 without correc-
tion) and asymptomatic 6.9 ± 7.5%, p = 0.343 (p = 0.034 with-
out correction)).
Smooth muscle changes
The smooth muscle structure of the muscularis propria was
assessed using α-SMA and desmin staining. As shown in
Suppl. Table 2, no significant differences were observed.
Figure 3a shows that fibrosis was not found in the circular
muscle layer of the control group. Fibrosis was present in 29%
(p = 0.083) of symptomatic and in 17% (p = 0.273) of asymp-
tomatic SB patients. The symptomatic and asymptomatic SCI
groups showed fibrosis in 14% (p = 0.243) and 15%
(p = 0.192) of cases, respectively. The longitudinal layer
showed fibrosis in 13% of control cases. Fibrosis was signif-
icantly more often found in all SB groups (symptomatic 71%,
p = 0.011, and asymptomatic 67%, p = 0.025) and SCI groups
(symptomatic 67%, p = 0.002, and asymptomatic 85%,
p < 0.001) (Fig. 3a–c).
The presence of polyglucosan inclusion bodies in the
muscularis propria was assessed by PAS staining [27, 28].
No inclusion body myopathy was found in the smooth muscle
of the control, SB, and SCI groups.
Discussion
The ENS of the colon plays an important role in the regulation
of motility. Although the ENS can largely function indepen-
dently, extrinsic input is needed to ensure proper bowel activ-
ity [11, 17]. The ENS is controlled by extrinsic innervation
from the lower spinal cord, where parasympathetic fibers fa-
cilitate contraction of the colonic musculature and sympathet-
ic fibers inhibit colon motility [17, 18]. Colon dysfunction
following SCI can be distinguished into two main types, de-
pendent on the level of the lesion: an upper motor neuron
syndrome and a lower motor neuron syndrome [4, 29]. The
upper motor neuron bowel is associated with spastic segmen-
tal contractions of the colon and decreased propulsive peristal-
sis, while the lower motor neuron bowel is associated with
areflexia and reduced colon motility. Both syndromes result
in constipation [29].
Disruption of the extrinsic nerve fibers as in patients with
SB and SCI results in changed ENS activity and subsequently
in impaired motor function of the bowel [1, 8, 20, 30]. We
expected histological changes in the intrinsic neuromuscular
apparatus of the colon, due to impaired extrinsic control. Main
alterations were expected in the myenteric plexus, which con-
trols motility [10, 11]. Histological evaluation of the neuro-
muscular structures (ENS, ICCs, smoothmuscle) may provide
b
c
a
Fig. 4 Percentage CD117-
positive cells (ICCs) around the
circumference of the myenteric
plexus (arrows). a Compared
with the control group, less ICCs
were found in the SB and SCI
groups, significant in the
symptomatic SCI group. b
Section without ICCs around the
myenteric plexus. c 60% of the
ganglion is surrounded by ICCs.
ICC interstitial cell of Cajal, SB
spina bifida, SCI spinal cord
injury. *p < 0.05 vs control. Scale
bars 100 μm
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insight in the pathophysiological mechanisms of neurogenic
bowel in SB and SCI.
In the current study, we observed four changes in the neuro-
muscular apparatus. First, in analogy with two studies that in-
vestigated the effect of spinal cord and (parasympathetic) pe-
ripheral nerve lesions on the ENS, we did find loss of ganglion
cells in the myenteric plexus of the colon. However, the sub-
mucosal plexus was considered to be normal [21, 31], which
we confirmed in our study. Upon analysis of subsets of neurons,
we observed loss of calretinin-positive neurons in the patient
groups. Calretinin is a biomarker for a subpopulation of neu-
rons including IPANs [32]. IPANs are sensory neurons which
play a role in the peristaltic reflex [33]. In contrast, in the
myenteric plexus, a reduction of the total neuron population
was observed, both in the symptomatic and asymptomatic SB
and SCI groups, which suggested that neuron loss could thus
not solely be responsible for severe motility complaints.
Second, we found lower fiber density in the symptomatic
but not in the asymptomatic groups. Since enteric glial cell
nuclei are more prominent than nerve fibers in the healthy
myenteric plexus, we believe that glial cells are lost in the
symptomatic groups. Although the exact function of glial cells
in intestinal motility is still unclear, they may have an impor-
tant role in the physiological control of motility and in enteric
neurotransmission [13, 34]. Loss of enteric glial cells might
impair bowel motility, as has been shown both in humans [35]
and mice [36]. Our findings provide supportive evidence for a
significant role of glial cells in the regulation of motility.
Whether reduction of nerve fibers initiates neuronal loss or
is a response to neuronal loss remains still unclear; further
research on this mechanism is needed.
Third, we found loss of the ICC network around the cir-
cumference of the myenteric plexus in almost all patients,
although after performing a strict statistic test (Kruskal-
Wallis) with correction for multiple testing, this was only sig-
nificant in the symptomatic SCI group. The small subgroups
resulted in low statistical power and lack of significance.
Scoring of the density of the ICC network has shown good
inter- and intraobserver agreement and reliability [26], but the
differences between our groups might be a result of rater var-
iability. A previous study indicated that only tissues with
completely absent ICCs may be diagnosed as abnormal in
the colon [26]. Several studies have shown that loss of ICCs
in patients with motility problems is highly associated with
changes of enteric nerves [37]. Consequently, in most motility
disorders, it is unclear whether ICC network disruption is
primary or secondary to neuronal changes [38]. We hypothe-
size that in our patients, ICC loss is indeed secondary to dis-
ruption of the extrinsic innervation in SB and SCI. Loss of the
myenteric ICC network was shown in most patients, while
approximately two thirds of this group revealed neuronal loss.
Therefore, disruption of the ICC network may precede loss of
enteric neurons.
Fourth, significantly more fibrosis was found in the longi-
tudinal muscle layer in almost all patients. Although fibrosis
in the longitudinal layer is frequently found in patients with
visceral myopathy [23, 39, 40], other muscle changes were
not observed in our patients. Nevertheless, the presence of
fibrosis might contribute to motility problems.
Despite SB being a congenital and SCI an acquired disease,
no clear differences between both conditions were found. All
observed alterations in the neuromuscular apparatus may be
explained as reactive to disrupted extrinsic innervation of the
colon. This is supported by a study in rats with
myelomeningocele, suggesting that the anorectal unit is nor-
mally developed [41]. This has led to the hypothesis that loss
of extrinsic innervation may result in trans-neuronal degener-
ation, although the exact mechanism in the bowel is currently
unknown [21, 31].
Our study has some limitations. First, we aimed to study
two large groups of patients to perform reliable compari-
sons which required collection of tissue blocks from SB and
SCI patients on a national scale. We used proper cross sec-
tions of the entire colonic wall, from mucosa to serosa, and
included cross sections in different directions to make the
groups as large as possible. Nevertheless, the groups, nota-
bly the SB groups, were relatively small which resulted in
low statistical power. Second, the anonymous character of
the study resulted in lack of data on the severity of motility
problems, the level of the lesion, the duration of the SCI,
mobility of patients (bedridden, use of wheelchair), and
medication. Patients in the symptomatic SB and SCI groups
had severe motility problems, which was the indication for
surgery. In contrast, of patients in the asymptomatic SB and
SCI groups, it remains unknown whether or not motility
was normal. These patients might have suffered from mo-
tility problems in less severe form, which would be support-
ed by the histological changes in these groups. Third, the
mean age in the SB groups was much lower than that in the
control group. Therefore, differences in enteric neuronal
numbers between controls and SB patients might be
underestimated as patients in the control group might have
lost neurons due to aging [42].
In conclusion, we have shown that impaired extrinsic
innervation affects neuromuscular structures which may
contribute to decreased bowel motility. Major neuromuscu-
lar alterations in the colon of SB and SCI patients are loss of
myenteric neurons and disruption of the ICC network
around the myenteric plexus, accompanied by decreased
nerve fiber density in the myenteric plexus. These changes
might affect intestinal motility, already symptomatic in
some patients and potentially symptomatic in others. In
addition, nerve fiber density (glial cells) in the myenteric
plexus was significantly decreased in the symptomatic SB
and SCI groups, which may be the reason for the major
motility problems found in these patients.
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